Literature DB >> 19690273

Cytokine gene expression after total hip arthroplasty: surgical site versus circulating neutrophil response.

Asokumar Buvanendran1, Kendall Mitchell, Jeffrey S Kroin, Michael J Iadarola.   

Abstract

BACKGROUND: After surgery, cytokines and chemokines are released at the surgical wound site, which can contribute to postoperative pain, local inflammation, and tissue repair. Multiple cell types are present that can release cytokines/chemokines at the wound site and, thus, the exact cellular source of these molecules is unclear. We sought to better understand the contribution of neutrophils to cytokine/chemokine gene expression at the surgical wound site during the initial postsurgery phase of total hip arthroplasty (THA).
METHODS: Hip drain fluid was collected at 24 h postsurgery from six patients undergoing standardized THA. In addition, venous blood was collected presurgery and 24 h postsurgery. Neutrophils were isolated, total RNA extracted, and a biotinylated cRNA probe generated. The probes were hybridized with a cDNA microarray containing approximately 100 oligonucleotide sequences representing various human cytokines/chemokines or receptor genes. Changes in gene expression seen in the microarray were verified by reverse transcription polymerase chain reaction.
RESULTS: In the microarray analysis of hip drain neutrophils, interleukin-1 receptor antagonist (IL1RN), interleukin-18 receptor 1 (IL18R1), macrophage migration inhibitory factor (MIF), and macrophage inflammatory protein 3alpha (CCL20) were upregulated, whereas interleukin-8 receptor beta (IL8RB/CXCR2) was consistently downregulated, compared with presurgery blood neutrophils. All of these changes were confirmed by reverse transcription polymerase chain reaction.
CONCLUSION: There is a distinct cytokine gene expression profile in neutrophils at the THA surgical wound site at 24 h postsurgery when compared with that found in presurgery circulating neutrophils. Understanding these changes may allow us to knowledgeably manipulate neutrophil activity to reduce postoperative pain and inflammation without impairing wound healing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690273      PMCID: PMC3378993          DOI: 10.1213/ane.0b013e3181ac1746

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  31 in total

Review 1.  Understanding the role of immune regulation in wound healing.

Authors:  Julie E Park; Adrian Barbul
Journal:  Am J Surg       Date:  2004-05       Impact factor: 2.565

2.  Chemokine changes during oral wound healing.

Authors:  Kevin McGrory; Catherine M Flaitz; John R Klein
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

3.  Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils.

Authors:  A K Samanta; J J Oppenheim; K Matsushima
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

4.  Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner.

Authors:  Waldiceu A Verri; Ieda R S Schivo; Thiago M Cunha; Foo Y Liew; Sergio H Ferreira; Fernando Q Cunha
Journal:  J Pharmacol Exp Ther       Date:  2004-03-29       Impact factor: 4.030

5.  Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged.

Authors:  Jeffrey L Apfelbaum; Connie Chen; Shilpa S Mehta; Tong J Gan
Journal:  Anesth Analg       Date:  2003-08       Impact factor: 5.108

6.  Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue.

Authors:  S H Ferreira; B B Lorenzetti; A F Bristow; S Poole
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

Review 7.  Wound healing: an overview of acute, fibrotic and delayed healing.

Authors:  Robert F Diegelmann; Melissa C Evans
Journal:  Front Biosci       Date:  2004-01-01

8.  Intraluminal antibodies to macrophage migration inhibitory factor decrease substance P induced inflammatory changes in the rat bladder and prostate.

Authors:  Katherine L Meyer-Siegler; Pedro L Vera
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects.

Authors:  Gilly Wolf; Raz Yirmiya; Inbal Goshen; Kerstin Iverfeldt; Linda Holmlund; Kiyoshi Takeda; Yehuda Shavit
Journal:  Pain       Date:  2003-08       Impact factor: 6.961

Review 10.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

View more
  4 in total

1.  A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma.

Authors:  Prasong Khaenam; Darawan Rinchai; Matthew C Altman; Laurent Chiche; Surachat Buddhisa; Chidchamai Kewcharoenwong; Duangchan Suwannasaen; Michael Mason; Elizabeth Whalen; Scott Presnell; Wattanachai Susaengrat; Kimberly O'Brien; Quynh-Ahn Nguyen; Vivian Gersuk; Peter S Linsley; Ganjana Lertmemongkolchai; Damien Chaussabel
Journal:  J Transl Med       Date:  2014-03-11       Impact factor: 5.531

2.  Relationship between serum and synovial fluid CCL20 concentrations with disease severity in primary knee osteoarthritis.

Authors:  Jian Guan; Yao Li; Luo-Bin Ding; Guang-Yuan Liu; Xiao-Fei Zheng; Wei Xue; Hua-Jun Wang
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-09-01       Impact factor: 2.041

3.  Endogenous opioids in wound-site neutrophils of sternotomy patients.

Authors:  Hamdy Awad; Motaz Abas; Haytham Elgharably; Ravi Tripathi; Tykie Theofilos; Sujatha Bhandary; Chittoor Sai-Sudhakar; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 4.  Sterile post-traumatic immunosuppression.

Authors:  Md Nahidul Islam; Benjamin A Bradley; Rhodri Ceredig
Journal:  Clin Transl Immunology       Date:  2016-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.